US Stock MarketDetailed Quotes

KRON Kronos Bio

Watchlist
  • 1.130
  • -0.040-3.42%
Close Jul 3 13:00 ET
67.91MMarket Cap-567P/E (TTM)

Kronos Bio Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-301.87%-23.9M
13.58%-78.58M
-11.08%-25.02M
-0.86%-22.59M
-11.12%-25.03M
74.68%-5.95M
22.89%-90.93M
61.51%-22.53M
-11.19%-22.39M
-11.13%-22.52M
Net income from continuing operations
-14.18%-29.96M
15.41%-112.67M
20.33%-25.32M
2.73%-31.37M
9.61%-29.74M
27.65%-26.24M
11.83%-133.2M
49.01%-31.78M
4.01%-32.26M
-13.24%-32.9M
Depreciation and amortization
-16.52%475K
-5.74%2.14M
-16.72%478K
-10.68%510K
2.66%579K
2.15%569K
14.62%2.27M
5.13%574K
9.18%571K
21.55%564K
Other non cash items
-0.88%790K
1.58%3.27M
25.75%928K
16.59%752K
-17.26%796K
-9.12%797K
24.45%3.22M
-17.17%738K
21.01%645K
39.83%962K
Change In working capital
-163.32%-8.59M
-4.89%5.88M
-645.21%-5.29M
66.22%2.6M
-927.65%-5M
346.41%13.57M
481.36%6.18M
116.60%971K
-62.51%1.56M
694.74%604K
-Change in prepaid assets
-264.23%-450K
-61.62%616K
-477.91%-650K
-106.23%-38K
147.00%1.03M
-32.51%274K
264.62%1.61M
104.50%172K
-79.02%610K
140.25%417K
-Change in payables and accrued expense
11.16%-4.76M
-175.78%-6.18M
-189.78%-1.42M
44.42%3.82M
-523.29%-3.22M
-269.35%-5.36M
412.57%8.16M
251.38%1.59M
58.19%2.65M
-60.76%760K
-Change in other current assets
--0
155.92%590K
137.25%393K
----
----
-100.00%-2K
-2,053.70%-1.06M
---1.06M
----
----
-Change in other current liabilities
-1,200.00%-65K
-129.17%-42K
-105.94%-56K
131.85%158K
-98.57%-139K
97.85%-5K
106.24%144K
255.61%943K
22.26%-496K
91.50%-70K
-Change in other working capital
-117.77%-3.32M
507.79%10.89M
-427.89%-3.56M
-28.68%-1.54M
-430.75%-2.68M
6,384.18%18.66M
-14,157.89%-2.67M
-77.37%-674K
-626.87%-1.2M
-16,700.00%-504K
Cash from discontinued investing activities
Operating cash flow
-301.87%-23.9M
13.58%-78.58M
-11.08%-25.02M
-0.86%-22.59M
-11.12%-25.03M
74.68%-5.95M
22.89%-90.93M
61.51%-22.53M
-11.19%-22.39M
-11.13%-22.52M
Investing cash flow
Cash flow from continuing investing activities
190.79%5.77M
305.97%66.37M
-0.55%31.56M
1,051.88%35.79M
113.19%5.37M
75.87%-6.36M
-150.56%-32.22M
-18.10%31.74M
-93.80%3.11M
-164.62%-40.73M
Net PPE purchase and sale
94.44%-7K
-17.68%-679K
40.38%-31K
-193.15%-214K
-258.14%-308K
65.57%-126K
86.46%-577K
89.12%-52K
92.12%-73K
93.63%-86K
Net investment purchase and sale
192.74%5.78M
311.87%67.05M
-0.62%31.59M
1,032.17%36M
113.98%5.68M
76.01%-6.23M
-146.55%-31.65M
-18.96%31.79M
-93.77%3.18M
-163.13%-40.64M
Cash from discontinued investing activities
Investing cash flow
190.79%5.77M
305.97%66.37M
-0.55%31.56M
1,051.88%35.79M
113.19%5.37M
75.87%-6.36M
-150.56%-32.22M
-18.10%31.74M
-93.80%3.11M
-164.62%-40.73M
Financing cash flow
Cash flow from continuing financing activities
-33.37%567K
126.68%191K
0
-80.92%851K
-168.19%-716K
-54.53%628K
-71.61%410K
Proceeds from stock option exercised by employees
----
-33.37%567K
126.68%191K
--0
----
----
-80.94%851K
-168.19%-716K
-54.53%628K
-71.61%410K
Cash from discontinued financing activities
Financing cash flow
--0
-33.37%567K
126.68%191K
--0
-8.29%376K
--0
-80.92%851K
-168.19%-716K
-54.53%628K
-71.61%410K
Net cash flow
Beginning cash position
-14.93%66.35M
-61.06%78M
-14.22%59.63M
-47.35%46.42M
-56.49%65.7M
-61.06%78M
-19.89%200.3M
-68.26%69.51M
-53.02%88.17M
5.25%151.01M
Current changes in cash
-47.37%-18.13M
90.48%-11.65M
-20.78%6.73M
170.76%13.2M
69.33%-19.28M
75.04%-12.3M
-145.87%-122.3M
145.36%8.49M
-159.55%-18.66M
-242.14%-62.84M
End cash Position
-26.60%48.22M
-14.93%66.35M
-14.93%66.35M
-14.22%59.63M
-47.35%46.42M
-56.49%65.7M
-61.06%78M
-61.06%78M
-68.26%69.51M
-53.02%88.17M
Free cash flow
-293.64%-23.91M
13.38%-79.26M
-10.96%-25.06M
-1.48%-22.8M
-12.06%-25.33M
74.54%-6.07M
25.11%-91.5M
61.73%-22.58M
-6.65%-22.47M
-4.58%-22.61M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
--
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -301.87%-23.9M13.58%-78.58M-11.08%-25.02M-0.86%-22.59M-11.12%-25.03M74.68%-5.95M22.89%-90.93M61.51%-22.53M-11.19%-22.39M-11.13%-22.52M
Net income from continuing operations -14.18%-29.96M15.41%-112.67M20.33%-25.32M2.73%-31.37M9.61%-29.74M27.65%-26.24M11.83%-133.2M49.01%-31.78M4.01%-32.26M-13.24%-32.9M
Depreciation and amortization -16.52%475K-5.74%2.14M-16.72%478K-10.68%510K2.66%579K2.15%569K14.62%2.27M5.13%574K9.18%571K21.55%564K
Other non cash items -0.88%790K1.58%3.27M25.75%928K16.59%752K-17.26%796K-9.12%797K24.45%3.22M-17.17%738K21.01%645K39.83%962K
Change In working capital -163.32%-8.59M-4.89%5.88M-645.21%-5.29M66.22%2.6M-927.65%-5M346.41%13.57M481.36%6.18M116.60%971K-62.51%1.56M694.74%604K
-Change in prepaid assets -264.23%-450K-61.62%616K-477.91%-650K-106.23%-38K147.00%1.03M-32.51%274K264.62%1.61M104.50%172K-79.02%610K140.25%417K
-Change in payables and accrued expense 11.16%-4.76M-175.78%-6.18M-189.78%-1.42M44.42%3.82M-523.29%-3.22M-269.35%-5.36M412.57%8.16M251.38%1.59M58.19%2.65M-60.76%760K
-Change in other current assets --0155.92%590K137.25%393K---------100.00%-2K-2,053.70%-1.06M---1.06M--------
-Change in other current liabilities -1,200.00%-65K-129.17%-42K-105.94%-56K131.85%158K-98.57%-139K97.85%-5K106.24%144K255.61%943K22.26%-496K91.50%-70K
-Change in other working capital -117.77%-3.32M507.79%10.89M-427.89%-3.56M-28.68%-1.54M-430.75%-2.68M6,384.18%18.66M-14,157.89%-2.67M-77.37%-674K-626.87%-1.2M-16,700.00%-504K
Cash from discontinued investing activities
Operating cash flow -301.87%-23.9M13.58%-78.58M-11.08%-25.02M-0.86%-22.59M-11.12%-25.03M74.68%-5.95M22.89%-90.93M61.51%-22.53M-11.19%-22.39M-11.13%-22.52M
Investing cash flow
Cash flow from continuing investing activities 190.79%5.77M305.97%66.37M-0.55%31.56M1,051.88%35.79M113.19%5.37M75.87%-6.36M-150.56%-32.22M-18.10%31.74M-93.80%3.11M-164.62%-40.73M
Net PPE purchase and sale 94.44%-7K-17.68%-679K40.38%-31K-193.15%-214K-258.14%-308K65.57%-126K86.46%-577K89.12%-52K92.12%-73K93.63%-86K
Net investment purchase and sale 192.74%5.78M311.87%67.05M-0.62%31.59M1,032.17%36M113.98%5.68M76.01%-6.23M-146.55%-31.65M-18.96%31.79M-93.77%3.18M-163.13%-40.64M
Cash from discontinued investing activities
Investing cash flow 190.79%5.77M305.97%66.37M-0.55%31.56M1,051.88%35.79M113.19%5.37M75.87%-6.36M-150.56%-32.22M-18.10%31.74M-93.80%3.11M-164.62%-40.73M
Financing cash flow
Cash flow from continuing financing activities -33.37%567K126.68%191K0-80.92%851K-168.19%-716K-54.53%628K-71.61%410K
Proceeds from stock option exercised by employees -----33.37%567K126.68%191K--0---------80.94%851K-168.19%-716K-54.53%628K-71.61%410K
Cash from discontinued financing activities
Financing cash flow --0-33.37%567K126.68%191K--0-8.29%376K--0-80.92%851K-168.19%-716K-54.53%628K-71.61%410K
Net cash flow
Beginning cash position -14.93%66.35M-61.06%78M-14.22%59.63M-47.35%46.42M-56.49%65.7M-61.06%78M-19.89%200.3M-68.26%69.51M-53.02%88.17M5.25%151.01M
Current changes in cash -47.37%-18.13M90.48%-11.65M-20.78%6.73M170.76%13.2M69.33%-19.28M75.04%-12.3M-145.87%-122.3M145.36%8.49M-159.55%-18.66M-242.14%-62.84M
End cash Position -26.60%48.22M-14.93%66.35M-14.93%66.35M-14.22%59.63M-47.35%46.42M-56.49%65.7M-61.06%78M-61.06%78M-68.26%69.51M-53.02%88.17M
Free cash flow -293.64%-23.91M13.38%-79.26M-10.96%-25.06M-1.48%-22.8M-12.06%-25.33M74.54%-6.07M25.11%-91.5M61.73%-22.58M-6.65%-22.47M-4.58%-22.61M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion----------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg